BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17015695)

  • 1. Selective availability of IL-2 is a major determinant controlling the production of CD4+CD25+Foxp3+ T regulatory cells.
    Yu A; Malek TR
    J Immunol; 2006 Oct; 177(8):5115-21. PubMed ID: 17015695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A function for IL-7R for CD4+CD25+Foxp3+ T regulatory cells.
    Bayer AL; Lee JY; de la Barrera A; Surh CD; Malek TR
    J Immunol; 2008 Jul; 181(1):225-34. PubMed ID: 18566388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-2Rbeta links IL-2R signaling with Foxp3 expression.
    Soper DM; Kasprowicz DJ; Ziegler SF
    Eur J Immunol; 2007 Jul; 37(7):1817-26. PubMed ID: 17559173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Function of the IL-2R for thymic and peripheral CD4+CD25+ Foxp3+ T regulatory cells.
    Bayer AL; Yu A; Malek TR
    J Immunol; 2007 Apr; 178(7):4062-71. PubMed ID: 17371960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-2R signaling is essential for functional maturation of regulatory T cells during thymic development.
    Cheng G; Yu A; Dee MJ; Malek TR
    J Immunol; 2013 Feb; 190(4):1567-75. PubMed ID: 23315074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PP2A enables IL-2 signaling by preserving IL-2Rβ chain expression during Treg development.
    Sharabi A; Li H; Kasper IR; Pan W; Meidan E; Tsokos MG; Moulton VR; Tsokos GC
    JCI Insight; 2019 Mar; 5(9):. PubMed ID: 30912768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells.
    Burchill MA; Yang J; Vogtenhuber C; Blazar BR; Farrar MA
    J Immunol; 2007 Jan; 178(1):280-90. PubMed ID: 17182565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditional ablation of MHC-II suggests an indirect role for MHC-II in regulatory CD4 T cell maintenance.
    Shimoda M; Mmanywa F; Joshi SK; Li T; Miyake K; Pihkala J; Abbas JA; Koni PA
    J Immunol; 2006 Jun; 176(11):6503-11. PubMed ID: 16709807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2.
    Malek TR; Yu A; Vincek V; Scibelli P; Kong L
    Immunity; 2002 Aug; 17(2):167-78. PubMed ID: 12196288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th3 cells in peripheral tolerance. II. TGF-beta-transgenic Th3 cells rescue IL-2-deficient mice from autoimmunity.
    Carrier Y; Yuan J; Kuchroo VK; Weiner HL
    J Immunol; 2007 Jan; 178(1):172-8. PubMed ID: 17182552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling.
    Elpek KG; Yolcu ES; Franke DD; Lacelle C; Schabowsky RH; Shirwan H
    J Immunol; 2007 Dec; 179(11):7295-304. PubMed ID: 18025172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-2, -7, and -15, but not thymic stromal lymphopoeitin, redundantly govern CD4+Foxp3+ regulatory T cell development.
    Vang KB; Yang J; Mahmud SA; Burchill MA; Vegoe AL; Farrar MA
    J Immunol; 2008 Sep; 181(5):3285-90. PubMed ID: 18714000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A low interleukin-2 receptor signaling threshold supports the development and homeostasis of T regulatory cells.
    Yu A; Zhu L; Altman NH; Malek TR
    Immunity; 2009 Feb; 30(2):204-17. PubMed ID: 19185518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal lymphoid homeostasis and lack of lethal autoimmunity in mice containing mature T cells with severely impaired IL-2 receptors.
    Malek TR; Porter BO; Codias EK; Scibelli P; Yu A
    J Immunol; 2000 Mar; 164(6):2905-14. PubMed ID: 10706676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-7 optimizes FOXP3+CD4+ regulatory T cells reactivity to interleukin-2 by modulating CD25 expression.
    Simonetta F; Gestermann N; Bloquet S; Bourgeois C
    PLoS One; 2014; 9(12):e113314. PubMed ID: 25485946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-2 induces in vivo suppression by CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Brandenburg S; Takahashi T; de la Rosa M; Janke M; Karsten G; Muzzulini T; Orinska Z; Bulfone-Paus S; Scheffold A
    Eur J Immunol; 2008 Jun; 38(6):1643-53. PubMed ID: 18493984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting edge: allogeneic CD4+CD25+Foxp3+ T regulatory cells suppress autoimmunity while establishing transplantation tolerance.
    Adeegbe D; Bayer AL; Levy RB; Malek TR
    J Immunol; 2006 Jun; 176(12):7149-53. PubMed ID: 16751356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells.
    Shameli A; Yamanouchi J; Tsai S; Yang Y; Clemente-Casares X; Moore A; Serra P; Santamaria P
    Eur J Immunol; 2013 Feb; 43(2):394-403. PubMed ID: 23180662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The control of CD4+CD25+Foxp3+ regulatory T cell survival.
    Pandiyan P; Lenardo MJ
    Biol Direct; 2008 Feb; 3():6. PubMed ID: 18304352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient IL-2R signaling differentially affects the stability, function, and composition of the regulatory T-cell pool.
    Permanyer M; Bošnjak B; Glage S; Friedrichsen M; Floess S; Huehn J; Patzer GE; Odak I; Eckert N; Zargari R; Ospina-Quintero L; Georgiev H; Förster R
    Cell Mol Immunol; 2021 Feb; 18(2):398-414. PubMed ID: 33408345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.